Jagsonpal Pharmaceuticals Limited develops and manufactures bulk drugs and pharmaceutical formulations in the areas of women health, pain and analgesics, and general medicine. It offers general medicines, such as allergy management, immunity and cell protection, gut and mind management, anti-infectives, and dentist and ENT range products; and women's healthcare products, including pregnancy care, and dysfunctional uterine bleeding complications and management products. The company also provides pain and analgesics products in the areas of pain management, and bone and joint care. It offers drugs in the form of tablets, capsules, and syrups. The company was founded in 1964 and is based in New Delhi, India. Jagsonpal Pharmaceuticals Limited is a subsidiary of Aresko Progressive Private Limited.
Jagsonpal Pharmaceuticals Dividend Announcement
• Jagsonpal Pharmaceuticals announced a annually dividend of ₹5.00 per ordinary share which will be made payable on 2024-10-18. Ex dividend date: 2024-09-06
• Jagsonpal Pharmaceuticals annual dividend for 2024 was ₹5.00
• Jagsonpal Pharmaceuticals annual dividend for 2023 was ₹5.00
• Jagsonpal Pharmaceuticals's trailing twelve-month (TTM) dividend yield is 0.73%
Jagsonpal Pharmaceuticals Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-09-06 | ₹5.00 | annually | 2024-10-18 |
2023-08-21 | ₹5.00 | annually | 2023-09-30 |
2021-10-29 | ₹4.00 | annually | 2021-11-18 |
2021-09-22 | ₹1.00 | annually | 2021-10-30 |
2020-09-22 | ₹0.50 | annually | 2020-10-30 |
2019-09-20 | ₹0.25 | annually | 2019-10-30 |
2018-09-18 | ₹0.10 | annually | 2018-10-28 |
2017-09-21 | ₹0.10 | annually | 2017-10-29 |
2016-09-21 | ₹0.10 | annually | |
2015-09-21 | ₹0.10 | annually | 2015-10-30 |
2014-09-25 | ₹0.50 | annually | 2014-10-30 |
2013-09-25 | ₹0.50 | annually | 2013-10-30 |
2012-09-21 | ₹0.50 | annually | 2012-10-28 |
Jagsonpal Pharmaceuticals Dividend per year
Jagsonpal Pharmaceuticals Dividend growth
Jagsonpal Pharmaceuticals Dividend Yield
Jagsonpal Pharmaceuticals current trailing twelve-month (TTM) dividend yield is 0.73%. Interested in purchasing Jagsonpal Pharmaceuticals stock? Use our calculator to estimate your expected dividend yield:
Jagsonpal Pharmaceuticals Financial Ratios
Jagsonpal Pharmaceuticals Dividend FAQ
Other factors to consider when evaluating Jagsonpal Pharmaceuticals as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Jagsonpal Pharmaceuticals stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Jagsonpal Pharmaceuticals's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Jagsonpal Pharmaceuticals publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Jagsonpal Pharmaceuticals distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Jagsonpal Pharmaceuticals are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Jagsonpal Pharmaceuticals sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Jagsonpal Pharmaceuticals distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Jagsonpal Pharmaceuticals declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Jagsonpal Pharmaceuticals's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Jagsonpal Pharmaceuticals's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.